Compare AbCellera Biologics Inc (ABCL) vs Infosys Limited (INFY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Infosys Limited — how do they compare? AbCellera Biologics Inc trades at $9.13 (market cap $2.99B), while Infosys Limited trades at $12.4 (market cap $50.55B). The key difference: Infosys Limited is far larger — about 16.9× AbCellera Biologics Inc's market cap, and Infosys Limited pays a 4.16% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | INFY | |
|---|---|---|
Market Cap | $2.99B | $50.55B |
Sector | Health | Technology |
52-Week High | $9.76 | $20.22 |
52-Week Low | $2.78 | $10.49 |
Enterprise Value | $2.58B | $48.30B |
Dividend Yield | — | 4.16% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Infosys Limited
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →
